Rapid Point-of-Care Detection for Serologic Status of Individuals for CMV and HSV Infection

Qoolabs, Inc., Carlsbad CA

Investigators

Abstract

To develop lateral flow immunoassays (LFIA) for CMV and HSV antibody detection that will be rapid, accurate, cost-effective and suitable for use at point-of-care.